TGFB1 and systemic sclerosis: In another study, J. Furuzawa et al. indicated that polymerized collagen has the capacity of downregulating the IL-22 level and other pro-inflammatory or profibrogenic cytokines (i.e., IL-17A and TGF-β1) in peripheral cells of SSc patients, renewing the skin architecture [86].